跳至主要内容

What are the Contents of the New Drug Preclinical Research?

 

Preclinical research content of new drugs:

  • Literature research (drug name and naming basis, title and basis)
  • Pharmaceutical research (raw material drug technology research, preparation prescription and technology research, etc.)
  • Pharmacology and toxicology research (general pharmacology experiment, main pharmacodynamic experiment, acute toxicity experiment, long-term toxicity experiment, etc.)

The stage and purpose of the clinical research of the new drug:

Phase I clinical trial (safety):

preliminary clinical pharmacology and human safety evaluation test. Observe the human body’s tolerance and pharmacokinetics of new drugs to provide a basis for formulating dosing regimens.

Phase II clinical trial (effectiveness):

the preliminary evaluation stage of the therapeutic effect. Its purpose is to preliminarily evaluate the therapeutic effect and safety of the drug on patients with target indications, and also to provide a basis for the design of phase III clinical trials and the determination of the dosage regimen.
The research design at this stage can adopt various forms according to specific research purposes, including randomized blinded controlled clinical trials.

Phase III clinical trial:

the stage of confirmation of the therapeutic effect. Its purpose is to further verify the therapeutic effect and safety of the drug on patients with target indications, evaluate the relationship between benefits and risks, and ultimately provide a sufficient basis for the review of drug registration applications. The test should generally be a randomized blinded controlled trial with sufficient sample size.

Phase IV clinical trials:

the application research phase of the new drug after it is marketed. Its purpose is to investigate the efficacy and adverse reactions of the drug under widely used conditions, to evaluate the relationship between benefits and risks in general or special populations, and to improve the dosage at the first level.
Bioequivalence test refers to the method of bioavailability research, using pharmacokinetic parameters as an indicator to compare the same or different dosage forms of the same drug, under the same test conditions, the absorption degree and speed of its active ingredients There are no statistical differences in human trials.

Contact Us:

Email : marketing@medicilon.com

Tel : +44 1223 981 792 (Europe)

+82 (0)70-8269-5849 (South Korea)

08044216898 (Japan)

+86 021 58591500 (China)

Website: https://www.medicilon.com

Related Articles:

Preclinical Drug Development Process

标签：

评论

发表评论

此博客中的热门博文

In Vitro Enzyme Activity Assay

  Kinases play extensive and important roles in signal transduction and co-ordination of complex functions. Currently, about 300 kinase inhibitors have been approved for marketing, among which receptor tyrosine kinase (RTK) inhibitors are the main ones. Medicilon provides high-quality kinase profile screening and has one-stop kinase research services from assay development, high-throughput screening to selectivity analysis. In addition, Medicilon provides many other enzyme activity screens. Wide Variety Provides 200+  in vitro  enzymatic detection methods; 100+ kinases, including CTK, RTK, AGC, CMGC and other kinase families as well as important common mutations Project Flexibility Various types of plates for screening, such as 96 and 384; Multiple flexible kinase profiles, including TK kinase family, CDK kinase family, etc., to meet different customer customization needs. Various Methods Fluorescence detection; Chemiluminescence detection; Absorbance detection LanthaScr...
发表评论
阅读全文

Fluorescence Probes Synthesis

Medicilon's fluorescent probes and labeling platforms can provide fluorescent probe design and synthesis services for scientific institutions, drug R&D companies, and other customers. Design and synthesis steps Fluorescent probes are tools used to detect, measure and analyze biomolecules, cells and tissues. They achieve these purposes by emitting and receiving fluorescent signals. Medicilon can complete the design and synthesis of fluorescent probes for biomolecules. Selection of target molecules and determination of target. Selection of fluorescent dyes. Design of molecular structure. Synthesize probe molecules. Testing the properties of probe molecules. Custom synthesis Medicilon's fluorescent probes and labeling platforms can provide fluorescent probe design and synthesis services for scientific institutions, drug R&D companies, and other customers. After years of development, Medicilon's fluorescent probes and labeling platforms have accumulated rich experience...
发表评论
阅读全文

Custom Synthesis

Medicilon has synthesized over 10,000 individual compounds from gram to kilogram quantities, and many compounds are synthesized with more than ten synthetic steps. The overall synthesis success rate is over 95%. High quality products from mg to kg scale Reagents, intermediates, building blocks, and scaffolds Preparation of API or reference standards Development of synthetic routes for impurities and metabolites   On-site analytical support Product delivered with COA Medicilon offers integrated drug discovery services -- Chemistry, Biology & Preclinical Services
发表评论
阅读全文